NDC11 00299392804
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00299-3928-04 | 00299-3928 |
| 00299-3928-4 | 00299-3928 |
| 0299-3928-04 | 0299-3928 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cetaphil | OCTOCRYLENE, AVOBENZONE | Galderma Laboratories, L.P. | 2a6bc3f2-4e52-252b-d051-94be1ee0cc00 | 2024-04-16 | Warnings | 0299-3928-04 0299-3928 00299392804 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.